Methods and Compositions for Increasing the Yield of, and Beneficial Chemical Composition of, Certain Plants

ABSTRACT

The present specification describes increasing the Brix degree, nutrient transport and density, and yields of cannabis crops through the application of photoacoustic resonance to a nutrient formulation. An activated nutrient solution is obtained by forming an unactivated nutrient solution and applying to the unactivated nutrient solution ultra-rapid impulses of modulated laser light, from one or more laser systems. An increase of at least 5% in the Brix degree of the crop, relative to an unactivated nutrient formulation, can be achieved. In addition, an increase of at least 5%, relative to an unactivated nutrient formulation, is seen with respect to nutrient density and crop yield through application of the activated nutrient solution.

CROSS-REFERENCE

The present application is a continuation application of U.S. patentapplication Ser. No. 15/694,721, entitled “Methods and Compositions forIncreasing the Yield of, and Beneficial Chemical Composition of, CertainPlants” and filed on Sep. 1, 2017, which relies on, for priority, U.S.Patent Provisional Application No. 62/383,091, entitled “Methods andCompositions for Increasing the Bioactivity of Nutrients”, and filed onSep. 2, 2016.

U.S. patent application Ser. No. 15/694,721 is also acontinuation-in-part of U.S. patent application Ser. No. 14/731,036, ofthe same title, filed on Jun. 4, 2015, and issued as U.S. Pat. No.10,040,728 on Aug. 7, 2018, which in turn, relies on U.S. PatentProvisional Application No. 62/009,024, filed on Jun. 6, 2014 andentitled “Methods and Compositions for Increasing the Bioactivity ofNutrients” and U.S. Patent Provisional Application No. 62/144,177, filedon Apr. 7, 2015 and entitled “Methods and Compositions for Increasingthe Bioactivity of Nutrients”.

The above-mentioned applications are herein incorporated by reference.

FIELD

The present specification is directed toward methods and compositionsfor increasing the bioactivity of nutrients and, more specifically, forincreasing the bioactivity of nutrients through the application ofphoto-acoustic resonance to increase the yield of agricultural products,specifically, cannabis.

BACKGROUND

Plant nutrients, which come primarily from chemical fertilizers, manure,and in some cases sewage sludge, are essential for crop production. Whenapplied in proper quantities and at appropriate times, nutrients(especially nitrogen, phosphorus, and potassium) help achieve optimumcrop yields. The profit potential for farmers depends on producingenough crops per hectare to keep production costs below the sellingprice. Efficient application of the correct types and amounts offertilizers for the supply of the nutrients is an important part ofachieving profitable yields. Further, to meet the continuouslyincreasing demand for food commodities, it is important to increase thenutrient density of nutrients applied to agricultural crops and developmethods for plants to absorb these nutrients more efficiently, therebyhelping farmers increase their crop output.

Nutrient density can be defined as the quantity of a nutrient per unitof weight of produce or sap. It is generally expressed in terms ofgrams/100 grams, as a percentage of weight of the given nutritionalcomponent in total weight for high quantity substances as in sucrose.

The sugar available to the plants from an applied nutrient solution maybe measured in degrees Brix (° Bx), which is defined as the sugarcontent of an aqueous solution. One degree Brix is 1 gram of sucrose in100 grams of solution and represents the strength of the solution aspercentage by weight (% w/w). The Brix degree can also be expressed asparts per million by weight in components present in relative traceamounts.

It is known that for every one point increase in the Brix degree, aseries of beneficial results, related to greater nutrient transport,occur, including, but not limited to, enhanced transport of nutrientsinto the cellular substance of the plant, increased sugar and proteincontent of the food, higher nutrient density for a given application ofnutrients, greater resistance to pests and pathological microbes (on theorder of 50% or greater improvement in resistance relative to cropstreated with unactivated nutrients), and significantly higher yields ofproduce per plant per hectare cultivated.

One exemplary crop that would benefit from increased nutrient density iscannabis. Cannabis comprises numerous different compositions whichdeliver varied therapeutic and medicinal benefits, including, but notlimited to, cannabinoids, terpenoids/terpenes, nitrogenous compounds,amino acids, proteins, enzymes, glycoproteins, sugars, hydrocarbons,fatty acids, simple esters and lactones, steroids, non-cannabinoidphenols, flavonoids, and vitamins. It would be beneficial if theconcentration and/or yield of one or more of those individual compoundswithin a cannabis crop can be increased through an improved nutrientsolution.

Accordingly, there is a need for improving large scale agricultural foodproduction and the nutrient density of crops. There is also a need toenhance the transport of nutrients in an organism in order to increasethe food item's Brix degree or other nutrient values. Accordingly, thereis a need for methods and compositions to enhance the transport ofnutrients, increase the Brix degree, increase the concentration and/oryield of individual compositions within a crop, and/or reliably achievethe above listed biological effects for a wide variety of nutrients andfood items.

SUMMARY

The present specification discloses a method of growing cannabiscomprising: applying an activated composition to an untreated cannabiscrop, wherein said activated composition comprises an amount ofphotoacoustic energy deposited therein in a range of 0.05 to 5milliwatt-minutes per liter; and wherein, after said application, thetreated cannabis crop exhibits an increased yield in a range of 5% to50% relative to the untreated cannabis crop.

Optionally, the method further comprises: forming an unactivatedcomposition; and applying to said unactivated composition a plurality ofultra-rapid impulses of modulated laser light, said ultra-rapid impulsesbeing defined as impulses with molecular traverse rates on the order of100 nanoseconds to 0.01 femtoseconds.

Optionally, said unactivated composition is water, a dry nutrient mix,or a liquid nutrient solution.

The treated cannabis crop may exhibit an increase in concentration of atleast one of cannabinoids, nitrogenous compounds, amino acids, proteins,enzymes, glycoproteins, sugars, hydrocarbons, alcohols, aldehydes,ketones, acids, fatty acids, esters, lactones, steroids, terpenoids,non-cannabinoid phenols, flavonoids, vitamins, pigments and elementsrelative to the untreated cannabis crop.

The treated cannabis crop may have an increased Brix degree in a rangeof 5% to 75% relative to the untreated cannabis crop.

The present specification also discloses a method of growing cannabiscomprising: applying an activated composition to an untreated cannabiscrop, wherein said activated composition comprises an amount ofphotoacoustic energy deposited therein in a range of 0.05 to 5milliwatt-minutes per liter; and wherein, after said application, atleast one of a plurality of cannabinoids constituents of said treatedcannabis crop has an increased amount in a range of greater than 5%relative to the untreated cannabis crop.

Optionally, the method further comprises: forming an unactivatedcomposition; and applying to said unactivated composition a plurality ofultra-rapid impulses of modulated laser light, said ultra-rapid impulsesbeing defined as impulses with molecular traverse rates on the order of100 nanoseconds to 0.01 femtoseconds.

Optionally, said unactivated composition is water, a dry nutrient mix,or a liquid nutrient solution.

Optionally, said plurality of cannabinoids constituents comprise atleast one of cannabigerolic acid, cannabigerol, cannabichromene,cannabidiolic acid, cannabidiol, and cannabinol.

The treated cannabis crop may have an increased Brix degree in a rangeof greater than 5% relative to the untreated cannabis crop.

The present specification also discloses a method of growing cannabiscomprising: applying an activated composition to an untreated cannabiscrop, wherein said activated composition comprises an amount ofphotoacoustic energy deposited therein in a range of 0.05 to 5milliwatt-minutes per liter; and wherein, after said application, atleast one of a plurality of terpene constituents of said treatedcannabis crop is increased by an amount in a range of greater than 5%relative to the untreated cannabis crop.

Optionally, the method further comprises: forming an unactivatedcomposition; and applying to said unactivated composition a plurality ofultra-rapid impulses of modulated laser light, said ultra-rapid impulsesbeing defined as impulses with molecular traverse rates on the order of100 nanoseconds to 0.01 femtoseconds.

Optionally, said unactivated composition is water, a dry nutrient mix,or a liquid nutrient solution.

Optionally, said plurality of terpene constituents comprise at least oneof alpha-pinene, myrcene, carene, beta-pinene, limonene, alpha-humulene,linalool, terpinolene, bisabolol, caryophyllene, and humulene.

A concentration of total terpene constituents in said treated cannabiscrop may increase by at least 5% relative to the untreated cannabiscrop.

The treated cannabis crop may have an increased Brix degree in a rangeof at least 5% relative to the untreated cannabis crop.

The present specification also discloses a treated cannabis cropprepared by applying an activated composition to an untreated cannabiscrop, wherein, after said application, the treated cannabis cropexhibits an increased yield in a range of 5% to 50% relative to theuntreated cannabis crop, and wherein said activated composition isprepared by a process comprising: forming an unactivated composition;and applying to said unactivated composition a plurality of ultra-rapidimpulses of modulated laser light, said ultra-rapid impulses beingdefined as impulses with molecular traverse rates on the order of 100nanoseconds to 0.01 femtoseconds.

Optionally, said unactivated composition is water, a dry nutrient mix,or a liquid nutrient solution.

The treated cannabis may exhibit an increase in concentration of atleast one of cannabinoids, nitrogenous compounds, amino acids, proteins,enzymes, glycoproteins, sugars, hydrocarbons, alcohols, aldehydes,ketones, acids, fatty acids, esters, lactones, steroids, terpenoids,non-cannabinoid phenols, flavonoids, vitamins, pigments and elementsrelative to the untreated cannabis crop.

The treated cannabis crop may have an increased Brix degree in a rangeof 5% to 75% relative to the untreated cannabis crop.

The present specification also discloses a treated cannabis cropprepared by applying an activated composition to an untreated cannabiscrop, wherein, after said application, at least one of a plurality ofcannabinoids constituents of said treated cannabis crop has an increasedamount in a range of greater than 5% relative to the untreated cannabiscrop, and wherein said activated composition is prepared by a processcomprising: forming an unactivated composition; and applying to saidunactivated composition a plurality of ultra-rapid impulses of modulatedlaser light, said ultra-rapid impulses being defined as impulses withmolecular traverse rates on the order of 100 nanoseconds to 0.01femtoseconds.

Optionally, said unactivated composition is water, a dry nutrient mix,or a liquid nutrient solution.

Optionally, said plurality of cannabinoids constituents comprises atleast one of cannabigerolic acid, cannabigerol, cannabichromene,cannabidiolic acid, cannabidiol, and cannabinol.

The treated cannabis crop may have an increased Brix degree in a rangeof greater than 5% relative to the untreated cannabis crop.

The present specification also discloses a treated cannabis cropprepared by applying an activated composition to an untreated cannabiscrop, wherein, after said application, at least one of a plurality ofterpene constituents of said treated cannabis crop is increased by anamount in a range of greater than 5% relative to the untreated cannabiscrop, and wherein said activated composition is prepared by a processcomprising: forming an unactivated composition; and applying to saidunactivated composition a plurality of ultra-rapid impulses of modulatedlaser light, said ultra-rapid impulses being defined as impulses withmolecular traverse rates on the order of 100 nanoseconds to 0.01femtoseconds.

Optionally, said unactivated composition is water, a dry nutrient mix,or a liquid nutrient solution.

Optionally, said plurality of terpene constituents comprises at leastone of alpha-pinene, myrcene, carene, beta-pinene, limonene,alpha-humulene, linalool, terpinolene, bisabolol, caryophyllene, andhumulene.

A concentration of total terpene constituents in said treated cannabiscrop may increase by at least 5% relative to the untreated cannabiscrop.

The treated cannabis crop may have an increased Brix degree in a rangeof at least 5% relative to the untreated cannabis crop.

The present specification is also directed toward increasing the Brixdegree of crops through the application of photoacoustic resonance to anutrient formulation, forming an activated nutrient formulation.

In one embodiment, an increase of at least 10% in the Brix degree of thecrop, relative to an unactivated nutrient formulation, can be achievedby treating the crop with an a laser activated nutrient solution. Inaddition, an increase of at least 10%, relative to an unactivatednutrient formulation, is seen with respect to nutrient density and cropyield through application of the activated nutrient solution.

In an embodiment, the present specification discloses a treated cannabiscrop prepared by applying an activated composition to an untreatedcannabis crop, wherein, after said application, the treated cannabiscrop exhibits an increased yield in a range of 5% to 50% relative to theuntreated cannabis crop, and wherein said activated composition isprepared by a process comprising: forming an unactivated composition;and applying to said unactivated composition a plurality of ultra-rapidimpulses of modulated laser light, said ultra-rapid impulses beingdefined as impulses with molecular traverse rates on the order of 100nanoseconds to 0.01 femtoseconds.

Optionally, said unactivated composition is water.

Optionally, said unactivated composition is a dry nutrient mix.

Optionally, said unactivated composition is a liquid nutrient solution.

Optionally, said treated cannabis crop exhibits an increase inconcentration of at least one of cannabinoids, nitrogenous compounds,amino acids, proteins, enzymes, glycoproteins, sugars, hydrocarbons,alcohols, aldehydes, ketones, acids, fatty acids, esters, lactones,steroids, terpenoids, non-cannabinoid phenols, flavonoids, vitamins,pigments and elements relative to the untreated cannabis crop.

Optionally, said treated cannabis crop has an increased Brix degree in arange of 5% to 75% relative to the untreated cannabis crop.

In some embodiments, the present specification discloses a treatedcannabis crop prepared by applying an activated composition to anuntreated cannabis crop, wherein, after said application, at least oneof a plurality of cannabinoids constituents of said treated cannabiscrop has an increased amount in a range of greater than 5% relative tothe untreated cannabis crop, and wherein said activated composition isprepared by a process comprising: forming an unactivated composition;and applying to said unactivated composition a plurality of ultra-rapidimpulses of modulated laser light, said ultra-rapid impulses beingdefined as impulses with molecular traverse rates on the order of 100nanoseconds to 0.01 femtoseconds.

Optionally, said unactivated composition is water.

Optionally, said unactivated composition is a dry nutrient mix.

Optionally, said unactivated composition is a liquid nutrient solution.

Optionally, said plurality of cannabinoids constituents comprise atleast one of cannabigerolic acid, cannabigerol, cannabichromene,cannabidiolic acid, cannabidiol, and cannabinol.

Optionally, said treated cannabis crop has an increased Brix degree in arange of greater than 5% relative to the untreated cannabis crop.

In some embodiments, the present specification discloses a treatedcannabis crop prepared by applying an activated composition to anuntreated cannabis crop, wherein, after said application, at least oneof a plurality of terpene constituents of said treated cannabis crop isincreased by an amount in a range of greater than 5% relative to theuntreated cannabis crop, and wherein said activated composition isprepared by a process comprising: forming an unactivated composition;and applying to said unactivated composition a plurality of ultra-rapidimpulses of modulated laser light, said ultra-rapid impulses beingdefined as impulses with molecular traverse rates on the order of 100nanoseconds to 0.01 femtoseconds.

Optionally, said unactivated composition is water.

Optionally, said unactivated composition is a dry nutrient mix.

Optionally, said unactivated composition is a liquid nutrient solution.

Optionally, said plurality of terpene constituents comprises at leastone of alpha-pinene, myrcene, carene, beta-pinene, limonene,alpha-humulene, linalool, terpinolene, bisabolol, caryophyllene, andhumulene.

Optionally, a concentration of total terpene constituents in saidtreated cannabis crop increases by at least 5% relative to the untreatedcannabis crop.

Optionally, said treated cannabis crop has an increased Brix degree in arange of at least 5% relative to the untreated cannabis crop.

The aforementioned and other embodiments of the present shall bedescribed in greater depth in the drawings and detailed descriptionprovided below.

BRIEF DESCRIPTION OF THE DRAWINGS

These and other features and advantages of the present invention will beappreciated, as they become better understood by reference to thefollowing detailed description when considered in connection with theaccompanying drawings, wherein:

FIG. 1A is a diagram illustrating an optical system for the modulationof a laser beam, in accordance with one embodiment of the presentspecification;

FIG. 1B is an illustration of an interference pattern produced by thesystem of FIG. 1;

FIG. 2 is a flowchart describing a method of photoacoustic stimulationof a nutrient solution, in accordance with one embodiment of the presentspecification;

FIG. 3A is a diagram showing one method for applying a modulated laserbeam to a nutrient solution;

FIG. 3B is a diagram showing another method for applying a modulatedlaser beam to a nutrient solution;

FIG. 4 is a table illustrating a plurality of chemical classes ofconstituents in cannabis and number of known constituents in eachchemical class;

FIG. 5 illustrates a table and a graph of a plurality of terpenes andtheir respective concentrations for cannabis flowers for control plants;

FIG. 6 illustrates a table and a graph of the plurality of terpenes andtheir respective concentrations for cannabis flowers for test plants;

FIG. 7A illustrates a table of a plurality of cannabinoids and theirrespective concentrations for cannabis flowers for control plants;

FIG. 7B illustrates a table of the plurality of cannabinoids and theirrespective concentrations for cannabis flowers for a first group of testplants, treated with a laser-activated nutrient formula;

FIG. 7C illustrates a table of the plurality of cannabinoids and theirrespective concentrations for cannabis flowers for a second group oftest plants, treated with laser-activated water;

FIG. 8A illustrates a table of a plurality of terpenes and theirrespective concentrations for cannabis flowers for control plants ofFIG. 7A; and,

FIG. 8B illustrates a table of the plurality of terpenes and theirrespective concentrations for cannabis flowers for a second group oftest plants, treated with laser-activated water, of FIG. 7C.

DETAILED DESCRIPTION

In one embodiment, the present specification discloses a method ofincreasing the nutrient density and Brix value derived from applyingactivated nutrient formulations or solutions to cannabis, thusincreasing the potency and efficacy of the nutrients supplied to theplants, which in turn improves the yield and quality of the overallcannabis crop as well as the individual therapeutic and medicinalcompositions, such as the constituent cannabinoids, terpenoids/terpenes,nitrogenous compounds, amino acids, proteins, enzymes, glycoproteins,sugars, hydrocarbons, fatty acids, simple esters and lactones, steroids,non-cannabinoid phenols, flavonoids, and vitamins. In an embodiment,photoacoustic stimulation is applied to a nutrient formulation to createan activated nutrient formulation which results in improved nutrientdensity in the cannabis crop when compared with an application of theunactivated nutrient formulation. In another embodiment, photoacousticstimulation is applied to water to create an activated water formulation(“lasered water”) which results in improved nutrient density in thecannabis crop when compared with an application of untreated water.

The present specification is directed towards multiple embodiments. Thefollowing disclosure is provided in order to enable a person havingordinary skill in the art to practice the invention. Language used inthis specification should not be interpreted as a general disavowal ofany one specific embodiment or used to limit the claims beyond themeaning of the terms used therein. The general principles defined hereinmay be applied to other embodiments and applications without departingfrom the spirit and scope of the invention. Also, the terminology andphraseology used is for the purpose of describing exemplary embodimentsand should not be considered limiting. Thus, the present invention is tobe accorded the widest scope encompassing numerous alternatives,modifications and equivalents consistent with the principles andfeatures disclosed. For purpose of clarity, details relating totechnical material that is known in the technical fields related to theinvention have not been described in detail so as not to unnecessarilyobscure the present invention.

It should be noted herein that any feature or component described inassociation with a specific embodiment may be used and implemented withany other embodiment unless clearly indicated otherwise.

In the description and claims of the application, each of the words“comprise” “include” and “have”, and forms thereof, are not necessarilylimited to members in a list with which the words may be associated.

Molecular resonance generated by laser radiation can be used for directstimulation of natural biological processes as described in U.S. Pat.No. 6,811,564, which is incorporated herein by reference in itsentirety.

FIG. 1A is a diagram illustrating an optical system for the modulationof a laser beam, in accordance with one embodiment of the presentspecification. Referring to FIG. 1A, the apparatus comprises a laserdiode 102 which is controlled by an amplitude modulator 101. The laserdiode 102 is selected such that it has a substantially linearrelationship between current and wavelength with minimum mode hopping.The amplitude modulator 101 modulates the current directed to the laserdiode which in turn results in a very small wavelength modulation of thelaser.

The output of the laser diode 102 is collimated by a lens 103 andpropagated towards an optical element 104. In one embodiment, theoptical element 104 consists of a first diffraction grating, arefractive element, and a second diffraction grating such that the beamis substantially cancelled. An exemplary form of an optical element isdisclosed in U.S. Pat. No. 6,064,500, which is incorporated herein byreference in its entirety. This allows the cancellation to occur over asmall percentage of the wavelength variance of the laser source, ratherthan at a single critical wavelength. Wavelengths beyond the acceptancebandwidth of the cancelling optical element 104 above and below thecenter frequency pass without being cancelled. This means that a complexFresnel/Fraunhoffer zone will be generated, defined by the beatfrequency of the high and low frequencies as a function of the aperture.Therefore, relatively sparse zones of constructive interference willoccur between the high and low frequency passes of the cancellationelement in selected directions from the aperture, as shown by theinterference pattern 150 in FIG. 1B.

As seen in FIG. 1A, the optical element can be adjusted angularlybetween positions 104A and 104B. In an embodiment, the output of thelaser diode is normal to the plane of the optical element 104A. Thisvaries the ratio of constructive to destructive interference. In effect,the continuous beam is transformed into a string of extremely shortduration pulses typically of sub-femtosecond duration. A nanosecond is abillionth of a second, and a femtosecond is a billionth of a nanosecond.The small wavelength modulation of the laser diode 102 causes theconstructive and destructive nodes to move rapidly through the volume ofthe Fresnel zone of the collimator lens aperture. This has the effect ofsimulating very short (sub-picosecond) pulse behavior at any point inthe Fresnel zone through which the nodes pass at a pulse repetitionfrequency defined by the amplitude modulator frequency.

If the beat frequency is made high enough, the wavelength of thecancelled to non-cancelled cycle can be a fraction of a practicalaperture. This will cause the wavelength to be sufficiently small, thuslimiting the Feynman paths to within a cycle or two in free spaceallowing the Fresnel/Fraunhoffer effect to be apparent. Since the centerfrequency and spectrum spread of a laser diode is easily modulated byadjusting the current and/or temperature of the junction, the pattern ofthe Fresnel/Fraunhoffer zones can be varied dramatically by very smallvariations in the wavelength of one or both pass frequencies. Suchmodulation is produced in the apparatus of FIG. 1A by the amplitudemodulator 101.

In effect, to the degree to which the optical device is adjusted toincrease the destructive interference, the nodes become commensuratelysparser, the measurable light output decreases, and the depth ofpenetration of the nodes through a medium increases.

As mentioned above, the effective pulse repetition frequency of suchnodes can reach impulse rates as fast as sub-femtoseconds. As molecularbond rotations and vibrations occur at rates on the order of 10femtoseconds, the output of this device can meet or exceed such ratesand entrain resonance of molecular bond vibrations. As demonstrated byOvokaitys and Strachan in U.S. Pat. No. 8,377,989, also incorporatedherein by reference in its entirety, this type of stimulation can buildthe free energy of chemical bonds in a system in which high free energystates of matter, such as room temperature stable non-crystallineaspirin, become possible. It is believed that an alternating sequence ofultra-short laser pulses provides photons that interact with multipleelectronic and/or vibrational states of the aspirin, disruptingintermolecular interactions, and, thus, preventing crystal formationand/or disrupting the crystal structure. The resultant non-crystallinestructure has a higher free energy in the intermolecular lattice thanany crystallized form or structure. This higher energy state was alsoreported by Johari et al. in Physical Chemistry Chemical Physics, 2000,2, 5479-5484, wherein a vitreous state of aspirin had a higher energystate than the crystal state. This imparts a higher solubility in waterto the non-crystalline form that can be about 2 to 8 times higher thanthat of the crystal form for similarly sized particles. Referring toU.S. Pat. No. 8,377,989, laser stimulation results in a stable increasein the free energy in the compound demonstrable throughFourier-transform infrared spectroscopy (FTIR) and powder X-raydiffraction (PXRD). The stable increase in free energy can also be shownin the preparation of non-crystalline forms of statins, includingezetimibe. This change in structure, or heightened state, is defined inthermodynamics as the known increase in free energy between acrystalline and a glass or non-crystalline compound, which translates tofaster solubility and greater bioavailability.

In addition, as demonstrated by Ovokaitys and Strachan in U.S. Pat. No.8,404,733, also incorporated herein by reference in its entirety, laserstimulation can build the free energy of chemical bonds in a system tocreate a blend of laser treated amino acid powders useful inregenerating active myocardial tissue. It is believed that short pulsesof laser light provide photons that interact with multiple electronicand/or vibrational states of the composition to provide the lasermodified blend of amino acid powders.

United States Patent Application Number 2004/0204746A1, alsoincorporated herein by reference in its entirety, discloses a method forimproving the bioavailability of a bioactive substance by subjecting thebioactive substance to laser radiation. Application of laser lightprocesses alters the bond structures of and shape of molecules insubjected compounds and thus alters the reaction characteristics suchthat certain preferred biological reactions can be enhanced.

In one embodiment, modulated laser stimulation is applied to drynutrient mixes, liquid nutrient formulations, or water. In oneembodiment, photoacoustic laser stimulation is applied to dry nutrientmixes, liquid nutrient formulations, or water. Preferably, the modulatedlaser stimulation is a modulated impulse stimulation, as describedabove, which, when applied to nutrient and nutrient formulations, isfound to have a profound effect on increasing the potency and efficacyof the nutrients. An impulse is a construct of the fluctuating traverseof sparse nodes as an interference pattern produced by relationshipsbetween holograms and the rapid and slight movement of center point oflaser wavelength, rather than simply in a fixed pulse produced from, forexample, an LRC circuit or other pulse wave form generator. In a sense,the impulse is a construct of interference fringe phenomena and beatfrequencies, rather than a precisely defined pulse. In one embodiment,the impulse stimulation is ultra-rapid. For purposes of thisspecification, ultra-rapid impulses are defined as impulses withmolecular traverse rates ranging from 100 nanoseconds to 0.01femtoseconds. A molecular traverse rate can be defined as the time ittakes for the impulse to go from one end to the other end of a molecule.Accordingly, an impulse may be viewed as an ultra-rapidly modulated beamwith a high pulse repetition frequency. Notwithstanding the above, itshould be appreciated that the compositions and methods disclosed hereinare not limited to the use of impulse stimulation or ultra-rapid impulsestimulation and may be implemented using less than ultra-rapid impulsestimulation or other forms of modulation laser stimulation.

FIG. 2 is a flowchart listing the steps involved in a method ofphotoacoustic stimulation of a nutrient or nutrient formulation, inaccordance with one embodiment of the present specification to form anactivated nutrient or nutrient formulation. Referring to FIG. 2, in step201, a collimated or near collimated laser beam from a laser diode ispassed through a phase cancellation optical element. The optical elementcancels several of the central lines of the laser frequency whileleaving the higher and lower frequencies generally intact, such that thebeat frequency of the passed frequencies forms a pattern of interferenceof constructive and destructive nodes. In step 202, the diameter of thelaser beam is set to a sufficiently low multiple of the wavelength ofthe beat frequency to allow a substantial Fresnel zone to be apparent inthe beam. Thereafter, in step 203, the optical element is adjusted toobtain the desired ratio of constructive to destructive interference. Inone embodiment, the optical element is adjusted such that the number ofdestructive nodes is in substantial majority relative to theconstructive nodes. The constructive interference only occurs overultra-short time periods, and, thus, results in ultra-short pulses oflight. These small, directed bursts of light are modulated at thefrequency of the desired molecule, as shown in step 204, resulting inthe desired molecular resonance effect.

The modulated laser beam is then applied to a desired nutrient solutionin step 205. In one embodiment, as shown in FIG. 3A, a quantity ofnutrient solution 302 is housed in a container 304. At least one laseremits a beam 306 that is configured to be applied to the nutrientsolution 302 at a trajectory that allows a full traverse of the beam 306from and/or through a first surface 304 a of the container to anopposing surface 304 b of the container.

In another embodiment, a quantity of nutrient solution 352 is housed ina first container 354 and transported to a second container 355 via aconduit 360, which is in fluid communication with both first container354 and second container 355. At least one laser emits a beam 356 thatis configured to be applied to the nutrient solution 352 at a trajectorythat allows a full traverse of the beam 356 through the conduit 360 suchthat the nutrient solution is activated as it passes through the conduit360. While the laser is shown to interact with the container or conduitvertically, it should be appreciated that the laser can interact in anydirection provided the trajectory allows a full traverse of the beamthrough the nutrient solution.

In one embodiment, photoacoustic stimulation or resonance (PAR), asdescribed above, is applied to a nutrient solution to create anactivated nutrient solution. In an embodiment, photoacoustic stimulationis applied to a wet nutrient solution, formulation or fertilizer. Inanother embodiment, photoacoustic stimulation is applied to a drynutrient formula. In another embodiment, photoacoustic stimulation isapplied to water without any added fertilizers or other nutrients. Inanother embodiment, photoacoustic stimulation is applied to individualnutrients which may be combined to create a dry or liquid nutrientsolution or formulation.

In various embodiments, each laser has a wavelength in a range of 400 to750 nanometers. Each system was adjusted to 60% phase cancellation sothe measured power output of the systems after this adjustment was inthe range of 0.7 to 2.2 milliwatts, with an average of 1.2 milliwattsper system.

In various embodiments, application of photoacoustic energy, via a laserbeam as described in the present specification, to a nutrient solutionresults in a structural change to the nutrient solution, such that anutrient solution subjected to said laser beam has a different structurewhen compared to the same nutrient solution prior to being subjected tosaid laser beam. In other words, the structure of the nutrient solutionis modified by said laser beam or photoacoustic energy. The structure ofthe nutrient solution is changed or modified in that photoacousticenergy is added or deposited to said nutrient solution. The applicationand deposition of photoacoustic energy builds or increases the freeenergy of chemical bonds within the nutrient solution. Similar to thediscussion above with respect to crystalline and glass ornon-crystalline forms of solids, such as aspirin, in a solution, anenergy difference (stable increase in free energy) in created when thesolution is subjected to laser stimulation. It is believed that anutrient solution transitions to a heightened free energy state whenultra-short laser pulses provides photons that interact with theintermolecular bonds within the nutrient solution. For example,photoacoustic energy, when subjected to a solution comprising water, istransmitted to the hydrogen bonds in the water, depositing energy in thebonds and creating a different structure. When subjected tophotoacoustic energy via said laser beam, the molecules in the nutrientsolution are transitioned to a higher energy state without breaking themolecular bonds or otherwise denaturing or degrading the nutrients.Therefore, the nutrient solution structure has changed in that it has ahigher level of deposited photoacoustic energy than before applicationof the laser beam.

In various embodiments, when the disclosed beams of light are passedthrough a bioactive substance, resonance causes modifications in themolecular structure of the molecules of the substance. This may be thefolding of the molecule, the promotion or inhibition of a certain“handed-ness” of a stereoisomeric molecule, or simply a modification inthe molecular dimensions of the molecule. By selectively controlling themolecules, however, significant changes can be made in bioavailability,and/or physiologic reaction to the molecule.

In an alternative embodiment, after the disclosed beams of light arepassed through a bioactive substance, molecules of the substance have anincreased energy state or energy level. Chemical bonds between atoms ina molecule form because the bonds make the situation more stable for theinvolved atoms, which generally means the sum energy level for theinvolved atoms in the molecule is lower than if the atoms were not sobonded. As separate atoms approach each other to covalently bond, theirorbitals affect each other's energy levels to form bonding andantibonding molecular orbitals. The energy level of the bonding orbitalsis lower, and the energy level of the antibonding orbitals is higher.For the bond in the molecule to be stable, the covalent bondingelectrons occupy the lower energy bonding orbital. A molecular energystate is the sum of its electronic, vibrational, rotational, nuclear,and translational components. Electrons in atoms and molecules canchange, or make transitions in, energy levels by emitting or absorbing aphoton of electromagnetic radiation, whose energy must be exactly equalto the energy difference between the two levels. If a molecule is at thelowest possible energy level, it and its electrons are said to be in theground state. If it is at a higher energy level, it is said to beexcited. Such a species can be excited to a higher energy level byabsorbing a photon whose energy is equal to the energy differencebetween the levels. Therefore, in various embodiments, molecules in anutrient solution or substance can transition to a higher energy levelor state by absorbing photons from beams of light as described in thepresent specification. Conversely, an excited species can go to a lowerenergy level by spontaneously emitting a photon equal to the energydifference. Alternatively, such molecular modifications do notnecessarily result in the degradation of the molecule, breaking ofatomic bonds within the molecule, or ionization of the molecule.

In various embodiments, the difference in structure is defined by theapplied energy in total millijoules per liter, which can be calculatedby 1 milliwatt (1 millijoule/sec) x number of second=number ofmillijoules. In various embodiments, after application of a laser beamin accordance with the present specification, a nutrient formulationcomprises a composition having an amount of photoacoustic energydeposited therein which is greater than the amount of photoacousticenergy therein prior to application of the laser beam. In variousembodiments, after application of a laser beam in accordance with thepresent specification, a nutrient formulation comprises a compositionhaving an amount of photoacoustic energy deposited therein in a range of0.05 to 5 milliwatt-minutes per liter. In one embodiment, afterapplication of a laser beam in accordance with the presentspecification, a nutrient formulation comprises a composition having anamount of photoacoustic energy deposited therein in a range of 0.05 to1.25 milliwatt-minutes per liter. In some embodiments, an amount ofphotoacoustic energy within a nutrient formulation before application ofa laser beam is in a range of 0-0.05 milliwatt-minutes per liter.

In an embodiment, a wet nutrient solution, formulation or fertilizercomprises, individually or in combination, water (H₂O) and one or moreof nitrogen (N), phosphorus (P), potassium (K), sulfur (S), calcium(Ca), magnesium (Mg), boron (B), chlorine (Cl), copper (Cu), iron (Fe),manganese (Mn), molybdenum (Mo), cobalt (Co), nickel (Ni), iodine (I),selenium (Se), chromium (Cr) and zinc (Zn).

In an embodiment, a dry nutrient formulation or fertilizer comprises,individually or in combination, one or more of nitrogen (N), phosphorus(P), potassium (K), sulfur (S), calcium (Ca), magnesium (Mg), boron (B),chlorine (Cl), copper (Cu), iron (Fe), manganese (Mn), molybdenum (Mo),cobalt (Co), nickel (Ni), iodine (I), selenium (Se), chromium (Cr) andzinc (Zn).

In an embodiment, the nutrient solution, formulation or fertilizercomprises just water (H₂O) without any added nutrients or fertilizers.It should be appreciated that the term “water” refers to any natural ortreated water supply that may be commonly used to water crops.

The nutrient solution, formulation or fertilizer- in dry or wet form, insome embodiments, comprises compounds such as urea, ammonium phosphate,ammonium nitrate, ammonium sulfate, potash and gypsum, individually orin combination with other compounds and elements.

In some embodiments, some or all of the components of the nutrientsolution are sourced from at least one of the following ingredients:kelp, dry fish, sea bird guano, fulvic acids, and/or free iodine. Itshould be appreciated that one of ordinary skill in the art could obtainany of the aforementioned nutrient elements or compounds from any sourceand that the present inventions are not limited to particular sources ofnutrients.

In one embodiment, when an activated liquid nutrient solution, anactivated dry nutrient mix, or activated water is applied toagricultural crops, specifically cannabis, several benefits occur.First, cannabis crop yields increase in a range of 5% to 50%, includingany increment therein, relative to cannabis crops treated with the same,but unactivated, liquid nutrient solution, dry nutrient mix, or water.Second, cannabis crops experience an increase in Brix degree in a rangeof 5% to 50%, including any increment therein, relative to cannabiscrops treated with the same, but unactivated, liquid nutrient solution,dry nutrient mix, or water. Third, individual constituents withincannabis, such as cannabinoids, terpenoids/terpenes, nitrogenouscompounds, amino acids, proteins, enzymes, glycoproteins, sugars,hydrocarbons, fatty acids, simple esters and lactones, steroids,non-cannabinoid phenols, flavonoids, and vitamins, increase inconcentration or mass in a range of 1% or greater, including anyincrement therein, relative to cannabis crops treated with the same, butunactivated, liquid nutrient solution, dry nutrient mix, or water.

In some embodiments, when an activated liquid nutrient solution,activated dry nutrient mix, or activated water is applied to cannabis,within one hour of said application, the treated cannabis productexhibits an increased Brix degree in a range of 5% to 50% relative tocrops treated with the same, but unactivated liquid nutrient solution,dry nutrient mix, or water within one hour of said application.

For the purposes of this specification, a growing season can be definedas when a crop is harvested, after a growing period initiating with theplanting of a seed, where the growing period can be from 2-3 weeks forfast growing crops, such as for radish, lettuce, broccoli, spinach,onion, carrot green peas, cucumber, pepper and tomatoes, to ten monthsor more for slower growing crops, such as wheat. The first stage growingperiod for a cannabis crop is typically in the range of 30 to 60 days,which is determined by the rate of growth and can span up to 150 daysfor slower growing crops. A typical flowering period, which is thesecond stage of growth, ranges from 40 to 75 days. The harvesting periodconventionally includes a drying period of one week in a drying roomwith circulating air, followed by a second drying period of 2 to 4 weeksin plastic film bags.

The cannabis plant and its products consist of a plurality of chemicalsor constituents some of which are unique to cannabis, for example, the70 cannabinoids, and the terpenoids, with about 140 members forming themost abundant class. Table 1 of FIG. 4, illustrates a plurality of knownor identified constituents of cannabis by chemical class 405 along witha number of known constituents 410 within each chemical class 405 (orsubclass). It should be appreciated that each of these constituentsincrease in concentration or mass in a range of 1% or greater, includingany increment therein, relative to cannabis crops treated with the same,but unactivated, liquid nutrient solution, dry nutrient mix, or water.These chemical or constituent classes 405 and the constituents orchemicals 410 therein are described as follows:

Cannabinoids

This class includes, but is not limited to, more than 70 knowncannabinoids sub-classified as a) cannabigerol (CBG) type includingcannabigerolic acid, cannabigerolic acid monomethyl ether, cannabigerol,cannabigerol monomethyl ether, cannabigerovarinic acid,cannabigerovarin, cannabinerolic acid; b) cannabichromene (CBC) typeincluding cannabichromenic acid, cannabichromene, cannabichromevarinicacid, cannabivarichromene, cannabichromevarin,2-Methyl-2-(4-methyl-2-pentenyl)-7-propyl-2H-1-b enzopyran-5-ol; c)cannabidiol (CBD) type including cannabidiolic acid, cannabidiol,cannabidiol monomethyl ether, cannabidiol-C4, cannabidivarinic acid,cannabidivarin, cannabidiorcol; d) Delta-9-tetrahydrocannabinol typeincluding delta-9-tetrahydrocannabinolic acid A,delta-9-tetrahydrocannabinolic acid B, delta-9-tetrahydrocannabinol,delta-9-tetrahydrocannabinolic acid-C4, delta-9-tetrahydrocannabinol-C4,delta-9-tetrahydrocannabivarinic acid, delta-9-tetrahydrocannabivarin,delta-9-tetrahydrocannabiorcolic acid, delta-9-tetrahydrocannabiorcol,delta-7-cis-iso-tetrahydrocannabivarin; e) delta-8-tetrahydrocannabinoltype including delta-8-tetrahydrocannabinolic acid A,delta-8-tetrahydrocannabinol; f) cannabicyclol (CBL) type includingcannabicyclolic acid, cannabicyclol, cannabicyclovarin; g) cannabielsoin(CBE) type including cannabielsoic acid A, cannabielsoic acid B,C3-cannabielsoic acid B, cannabielsoin, C3-cannabielsoin; h) cannabinol(CBN) type including cannabinolic acid A, cannabinol, cannabinol methylether, cannabinol-C4, cannabivarin, cannabinol-C2, cannabiorcol-C1; i)cannabinodiol (CBND) type including cannabinodiol, cannabinodivarin; j)cannabitriol (CBT) type including (−)-trans-cannabitriol,(+)-trans-cannabitriol, (±)-cis-cannabitriol,(±)-trans-cannabitriol-C3, CBT-C3-homologue,(−)-trans-10-Ethoxy-9-hydroxy-Delta 6a(10a)-tetrahydrocannabinol,trans-10-Ethoxy-9-hydroxy-Delta 6a(10a)- tetrahydrocannabivarin-C3,8,9-Dihydroxy-Delta 6a(10a)-tetrahydrocannabinol, cannabidiolic acidtetrahydrocannabitriol ester; k) miscellaneous type includingdehydrocannabifuran, cannabifuran, cannabichromanone,cannabichromanone-C3, cannabicoumaronone-C5, cannabicitran, 10-Oxo-Delta6a(10a)-Tetrahydrocannabinol,(−)-Delta-9-(6aS,10aR-cis)-Tetrahydrocannabinol, cannabiglendol-C3,(−)-(6aR,9S,10S,10aR)-9,10-Dihydroxyhexa-hydrocannabinol,(−)-6a,7,10a-Trihydroxy-Delta-9-tetrahydrocannabinol,(±)-Delta-7-cis-(1R,3R, 6 S)-Isotetrahydrocannabivarin-C3,(−)-Delta-7-trans-(1R,3R, 6R)-Isotetrahydrocannabivarin-C3,(−)-Delta-7-trans-(1R,3R,6R)-Isotetrahydrocannabinol-C5. 11 additionalcannabinoid esters include β-fenchyl Delta-9-tetrahydrocannabinolate,epi-bornyl Delta-9-tetrahydrocannabinolate, α-terpenylDelta-9-tetrahydrocannabinolate, 4-terpenylDelta-9-tetrahydrocannabinolate, α-cadinylDelta-9-tetrahydrocannabinolate, γ-eudesmylDelta-9-tetrahydrocannabinolate, γ-eudesmyl cannabigerolate, 4-terpenylcannabinolate, bornyl Delta-9-tetrahydrocannabinolate, α-fenchylDelta-9-tetrahydrocannabinolate, α-cadinyl cannabigerolate.

Cannabinoids, which are secreted by cannabis flowers, provide relief formany symptoms, including inflammation, nausea and pain. Cannabinoidsmimic compounds, called endocannabinoids, which are naturally producedby the human body and which mediate communication between cells. Whenthe endocannabinoid system is not functioning properly, the human bodycan experience physical discomfort or unpleasant symptoms.

Cannabinoids bind to receptor sites throughout our brain (CB-1) and body(CB-2), and depending upon which receptors they bind to, can havedifferent effects. THC binds to the brain receptors, while cannabinolhas a stronger affinity for the body receptors.

Terpenoids/Terpenes

This class includes, but is not limited to 140 different terpenesbelonging to monoterpenoids (C10 skeleton), sesquiterpenoids (C15),diterpenoids (C20), and triterpenoids (C30) groups. Terpenoids may beacyclic, monocyclic, or polycyclic hydrocarbons with substitutionpatterns including alcohols, ethers, aldehydes, ketones, and esters.Following are some of the terpenoids: mycrene, limonene, linalool,trans-ocimene, beta-pinene, alpha-pinene, beta-caryophyllene,delta-3-carene, trans-gamma-bisabolene, trans-alpha-farnesene,beta-fenchol, beta-phellandrene, alpha-humulene, guajol, apha-guaiene,alpha-eudesmol, terpinolene, alpha-selinene, alpha-terpineol, fenchone,camphene, cis-sabinene hydrate, cis-ocimene, beta-eudesmol,beta-selinene, alpha-trans-bergamotene, gamma-eudesmol, borneol,cis-beta-farnesene, gamma-curcumene, cis-gamma-bisabolene,alpha-thujene, epi-alpha-bisabolol, ipsdienol, alpha-ylangene,beta-elemene, alpha-cis-bergamotene, gamma-muurolene, alpha-cadinene,alpha-longipinene, caryophyllene oxide.

Terpenes have the ability to act synergistically with cannabinoids aswell as other compounds in the plant. Terpenes are thought to bind tothe brain's receptors where they affect their chemical output, and,possibly modify how much THC passes through the blood-brain barrier.Terpene may also influence neurotransmitters such as dopamine andserotonin by altering their rate of production, their movement, and theavailability of receptor sites. The effects vary among the differentterpenes. It should also be noted that CBDs are 21-chain carbonmolecules which are difficult for the body to absorb, while terpenes are6-8 carbon chain molecules and can facilitate the ability of the body toabsorb CBDs.

Alpha-pinene and beta-pinene, for example, are used to enhancealertness, memory retention and may even counteract some of the effectsof THC. Myrcene is said to have a sedative, relaxing effect and can beused for relieving muscle tension, sleeplessness, pain, inflammation,and depression. Limonene is used to elevate mood and relieve stress, aswell as act as an antifungal, anti-bacterial, and anti-carcinogenic.Beta-Caryophyllene is used for its gastroprotective andanti-inflammatory properties. Linalool is said to have anxiolytic andsedative properties.

Nitrogenous Compounds

This class includes, but is not limited to, 5 quaternary bases, 8 amides(N-trans-Feruloyltyramine, N-p-Coumaroyltyramine,N-trans-Caffeoyltyramine) of which 5 are lignanamides (grossamide,cannabisin-A, B, C, D), 12 simple amines, and 2 spermidine typealkaloids named cannabisativine and anhydrocannabisativine.

Amino acids

This class includes, but is not limited to, at least 18 amino acidscommon in all plants including cannabis. The only amino acids notreported in cannabis are cysteine, asparagine, glutamine, hydroxyprolineand hydroxylysine.

Proteins, Enzymes and Glycoproteins

This class includes, but is not limited to, 3 proteins (edestin, zeatinand zeatinnucleoside), 6 enzymes (edestinase, glucosidase, polyphenoloxidase, peptidase, peroxidase and adenosine-5-phosphatase) and 2glycoproteins of unknown structure.

Sugars and Related Compounds

This class includes, but is not limited to, 13 monosaccharides(fructose, galactose, arabinose, glucose, mannose, rhamnose, etc.), 2disaccharides (sucrose, maltose), 5 polysaccharides (raffinose,cellulose, hemicellulose, pectin, xylan), 12 sugar alcohols andcyclitols (mannitol, sorbitol, glycerol, inositol, quebrachitol, etc.)and 2 amino sugars (galactosamine, glucosamine).

Hydrocarbons

This class includes, but is not limited to, 50 known hydrocarbonsconsisting primarily straight chain hydrocarbons ranging from C9 to C39with a few branched hydrocarbons in which one or two methyl groups formsubstituents along the main chain.

Simple Alcohols, Aldehydes, Ketones and Acids

This class includes, but is not limited to, 7 alcohols (e.g., methanol,ethanol, 1-octene-3-ol), 12 aldehydes (e.g., acetaldehyde,isobutyraldehyde, pentanal), 13 ketones (e.g., acetone, heptanone-2,2-methyl-2-heptene-6-one), and 21 acids (e.g., arabinic acid, azealicacid, gluconic acid).

Fatty Acids

This class includes, but is not limited to, 33 different fatty acids,mainly unsaturated fatty acids such as linoleic acid, α- linolenic acid,oleic acid, γ-linolenic acid, stearidonic acid, eicosanoic acid,cis-vaccenic acid, and isolinolenic acid. The saturated fatty acids arepalmitic acid, stearic acid, arachidic acid, behenic acid, myristicacid, lignoceric acid, caproic acid, heptanoic acid, caprylic acid,pelargonic acid, capric acid, lauric acid, margaric acid, andisoarachidic acid.

Simple Esters and Lactones

This class includes, but is not limited to include 12 esters and 1lactone. The esters are mainly low molecular weight organic acids, withtwo methyl esters of the fatty acids palmetic and linoleic. There is onearomatic acid ester (methyl salicylate). The only lactone is2-C-methyl-aldoteronolactone.

Steroids

This class includes, but is not limited to, 11 phytosterols belonging tothe stigmasterol, β-sitosterol, compesterol, and ergosterol types.

Non-Cannabinoid Phenols

This class includes, but is not limited to, 34 non-cannabinoid phenols:9 with spiro-indan-type structure (e.g., cannabispiran,isocannabispiran), 9 dihydrostilbenes (e.g., cannabistilbene-I, II), 3dihydrophenanthrenes (e.g., cannithrene-1, -2), and 6 phenols, phenolmethylethers, and phenolic glycosides (phloroglucinol glucoside).

Flavonoids

This class includes, but is not limited to 23 flavonoids existing mainlyas C-/O- and O-glycosides of the flavon- and flavonol-type aglyconesapigenin, luteolin, quercetin, and kaempferol along with 2 flavonolglycosides namely kaempferol 3-O-sophoroside and quercetin3-Osophoroside. Orientin, vitexin, luteolin-7-O-glucoside, andapigenin-7-O-glucoside are the major flavonoid glycosides present inlow-THC Cannabis cultivars.

Vitamins This class includes, but is not limited to, Vitamin K. PigmentsThis class includes, but is not limited to 2 pigments: carotene andxanthophylls. Elements

This class includes, but is not limited to 9 elements: Na, K, Ca, Mg,Fe, Cu, Mn, Zn, Hg. In some embodiments, when an activated liquidnutrient solution, activated dry nutrient mix, or activated water isapplied to cannabis, by the end of the growing season, the treatedcannabis has an increased yield per hectare in a range of 5% to 50%relative to cannabis crops treated with the same, but unactivated,liquid nutrient solution, dry nutrient mix, or water.

In some embodiments, when an liquid nutrient solution, activated drynutrient mix, or activated water is applied to cannabis, by the end of agrowing season, the treated cannabis delivers an enhanced transport ofnutrients to its cells and sap in a range of 5% to 400% greater relativeto cannabis crops treated with the same, but unactivated, liquidnutrient solution, dry nutrient mix, or water.

In some embodiments, when an liquid nutrient solution, activated drynutrient mix, or activated water is applied to cannabis, within one hourafter said application, the treated cannabis has a 5% to 50% increasedamount of at least one of sugar content or protein content relative tocannabis crops treated with the same, but unactivated, liquid nutrientsolution, dry nutrient mix, or water.

In some embodiments, when an liquid nutrient solution, activated drynutrient mix, or activated water is applied to cannabis, by the end of agrowing season, the treated cannabis product has a 1% to 400% highernutrient concentration or mass relative to cannabis crops treated withthe same, but unactivated, liquid nutrient solution, dry nutrient mix,or water. In some embodiments, when an liquid nutrient solution,activated dry nutrient mix, or activated water is applied to cannabis,within one hour after said application, the treated cannabis has a 50%or greater resistance to pests and pathological microbes to relative tocannabis crops treated with the same, but unactivated, liquid nutrientsolution, dry nutrient mix, or water.

In some embodiments, when an liquid nutrient solution, activated drynutrient mix, or activated water is applied to cannabis, by the end of agrowing season, a portion of the plurality of said cannabis has anincreased yield per hectare in a range of 5% to 100% relative toagricultural products cultivated with the same, but unactivated, liquidnutrient solution, dry nutrient mix, or water.

In some embodiments, when an liquid nutrient solution, activated drynutrient mix, or activated water is applied to cannabis, within one hourafter said application, a portion of the cannabis has an increased Brixdegree in a range of 5% to 75% relative to cannabis cultivated with thesame, but unactivated, liquid nutrient solution, dry nutrient mix, orwater.

In an embodiment, the agricultural product or crops include, but are notlimited to, cannabis, hemp and its varietals. Cannabis refers to theplant genus cannabis including three species or subspecies—sativa,indica and ruderalis. For the present specification, the term cannabiscomprises any part of the plant genus cannabis whether growing or not,the seeds thereof, the resin extracted from any part of the plant,including hashish and hash oil, any compound, manufacture, salt,derivative, mixture, or preparation of the plant, its seeds or resin. Itincludes the mature stalks of the plant, fiber produced from the stalks,oil or cake made from the seeds of the plant, any other compound,manufacture, salt, derivative, mixture, or preparation of the maturestalks, or a sterilized seed of the plant which is incapable ofgermination.

In some embodiments, when an activated liquid nutrient solution,activated dry nutrient mix, or activated water is applied to cannabis,by the end of the growing season, the treated cannabis has an increasedyield per pound in a range of 5% to 75% relative to cannabis cropstreated with the same, but unactivated, liquid nutrient solution, drynutrient mix, or water.

Nutrient/Water Preparation

In an embodiment, a container of 400 liters of the nutrient formulationwas treated with an array of four lasers. Each laser had a wavelength of674 nanometers and a power output in the range of 1.9 to 5.2 milliwattsafter passing through the optical device when adjusted for the minimumdegree of phase cancellation of the laser output.

In an embodiment, a container of 400 liters of water was treated with anarray of four lasers. Each laser had a wavelength of 674 nanometers anda power output in the range of 1.9 to 5.2 milliwatts after passingthrough the optical device when adjusted for the minimum degree of phasecancellation of the laser output.

All four beams were applied to the container of either nutrient solutionor water at a trajectory allowing a full traverse of the beam from thesurface to the bottom or opposite side of the container or conduitcarrying the nutrient solution. In one embodiment, application time ofthe beam was 20 minutes for each system. Thus, there was approximately96 milliwatt-minutes of visible residual beam applied to 400 liters ofnutrient solution or water to complete the treatment, or about 0.24milliwatt-minutes per liter.

Exemplary Protocol 1: Cannabis (Strain: Super Silver Haze, Sample TypeFlower)

In an embodiment, a nutrient formulation or solution was preparedconsisting of one or more of the aforementioned nutrient or fertilizercomponents. It should be appreciated that in various embodiments thenutrient formulation or solution can be organic or non-organic.

In one embodiment, a container of 400 liters of the nutrient formulationwas treated with an array of four lasers. Each laser had a wavelength of674 nanometers and a power output in the range of 1.9 to 5.2 milliwattsafter passing through the optical device when adjusted for the minimumdegree of phase cancellation of the laser output.

All four beams were applied to the nutrient solution at a trajectoryallowing a full traverse of the beam from the surface to the bottom oropposite side of the container or conduit carrying the nutrientsolution. In one embodiment, application time of the beam was 20 minutesfor each system. Thus, there was approximately 96 milliwatt-minutes ofvisible residual beam applied to 400 liters of nutrient solution tocomplete the treatment, or about 0.24 milliwatt-minutes per liter.

The nutrient formulation, thus activated by photoacoustic resonance(PAR), was then studied for its effects on a cannabis test group andcompared with a cannabis control group that is treated with theun-activated nutrient formula.

The nutrient formulation, thus activated by photoacoustic resonance(PAR), was then studied for its effects on cannabis (strain: supersilver haze, sample type: flower) compared to control cannabis (strain:super silver haze, sample type: flower). There were 10 plants in each ofthe control and test groups. Cannabis plants, in the control and testgroups, were characterized by a growing period ranging from 45 to 60days (as determined by the rate of growth), a flowering period of 56 to60 days followed by a drying period of 1 week in a drying room withcirculating air and an additional 2 to 4 weeks in plastic film bags.

The test group was treated with activated or laser enhanced formulafoliar sprayed two times per week at 5 PM throughout the growing andflowering cycle. An initial application of the activated formula wasstarted 7 to 10 days following permanent transplant. The activatedformula was provided in concentrated form which was diluted 10 ml to 1liter of water (ratio of 1 to 100) for the foliar spray. During thegrowing phase water used to dilute the activated formula was in a pHrange of 6.8 to 7 while during the flowering phase the pH range of thewater was in a range of 5 to 6. The concentrated activated formula usedfor treating the test group was stored at a separation space of at least33 feet from un-activated formula used for treating the control group aswell as conventional fertilizers and/or nutrients. The tracks for thetest and control plants were also isolated from each other by at least33 feet.

The control group was treated with un-activated formula and was providedwith the same growing conditions as the test group in terms of water,light exposure and conventional fertilizers and/or nutrients.

In one embodiment, 10 flowers from each of the control and test groupswere chosen randomly and analyzed for their terpenes concentration.

FIG. 5 shows a first table 505 and an associated first graph 506 of aplurality of terpenes 502 and their respective concentrations in ppm 507(parts per million) and mg/g 508 based on an analysis of the flowerstaken from the control group. FIG. 6 shows a second table 610 and anassociated second graph 611 of the plurality of terpenes 602 and theirrespective concentrations in ppm 612 (parts per million) and mg/g 613based on an analysis of the flowers taken from the test group. Comparingtables 505, 610 (and the respectively associated graphs 506, 611), inaccordance with an aspect, the total concentration 614 of the pluralityof terpenes 602 in the test group is increased compared to thecorresponding total concentration 509 of the plurality of terpenes 502in the control group. It should be appreciated that terpenes areconsidered to have medicinal or beneficial pharmacologicalcharacteristics without significant harmful side effects and/or reducethe side-effects of other toxic constituents of cannabis. Therefore, anincrease in concentration of the terpenes is desirable.

In some embodiments, a concentration of at least the following terpenesis modulated: alpha-pinene increases from 0.5 mg/g in the control groupto 0.6 mg/g in the test group representing about 20% increase, myrceneincreases from 4.5 mg/g in the control group to 7.6 mg/g in the testgroup representing about 69% increase, carene increases from 0.8 mg/g inthe control group to 0.9 mg/g in the test group representing about 13%increase, limonene increases from 1.5 mg/g in the control group to 2.4mg/g in the test group representing about 60% increase, terpinoleneincreases from 0.0 mg/g in the control group to 0.1 mg/g in the testgroup, B-caryophyllene increases from 3.3 mg/g in the control group to4.1 mg/g in the test group representing about 24% increase, humuleneincreases from 1.2 mg/g in the control group to 1.4 mg/g in the testgroup representing about 17% increase.

In some embodiments, concentration of at least the following terpenes,in the test group, increases by at least 1% compared to the controlgroup: alpha-pinene, myrcene, carene, limonene, terpinolene,B-caryophyllene, humulene.

In some embodiments, a concentration of total terpenes increases from13.6 mg/g in the control group to 17.4 mg/g in the test grouprepresenting an increase of about 28%. In some embodiments, compared tothe control group a concentration of total terpenes is increased by atleast 3 mg/g in the test group. In some embodiments, compared to thecontrol group a concentration of total terpenes is increased by at least20% in the test group. In some embodiments, compared to the controlgroup a concentration of total terpenes is increased by at least 1% inthe test group

In some embodiments, 10 plants from the control group yielded 3.4 poundsof cannabis flower while 10 plants from the test group yielded 4.7pounds of cannabis flower. In some embodiments, compared to the controlgroup a cannabis flower yield from 10 plants is increased by 1.3 poundsrepresenting an increase of about 38%. In some embodiments, compared tothe control group a cannabis flower yield from 10 plants is increased byat least 1%.

In some embodiments, concentration of at least the following terpenes,in the test group, is improved compared to the control group:alpha-pinene increases by 0.1 mg/g or at least 1%, myrcene increases by3.1 mg/g or at least 1%, carene increases by 0.1 mg/g or at least 1%,limonene increases by 0.9 mg/g or at least 1%, terpinolene increases by0.1 mg/g or at least 1%, B-caryophyllene increases by 0.8 mg/g or atleast 1%, humulene increases by 0.2 mg/g or at least 1%.

In some embodiments, a concentration of total terpenes, in the testgroup, increases by 3.8 mg/g or at least 1% compared to the control. Insome embodiments, compared to the control group a concentration of totalterpenes is increased by at least 3 mg/g in the test group. In someembodiments, compared to the control group a concentration of totalterpenes is increased by at least 20% in the test group.

Exemplary Protocol 2: Cannabis (Strain: Blackberry; Sample Type: Flower)

In an embodiment, a nutrient formulation or solution was preparedconsisting of one or more of the aforementioned nutrient or fertilizercomponents. It should be appreciated that in various embodiments thenutrient formulation or solution can be organic or non-organic.

In one embodiment, a container of 400 liters of the nutrient formulationwas treated with an array of four lasers. Each laser had a wavelength of674 nanometers and a power output in the range of 1.9 to 5.2 milliwattsafter passing through the optical device when adjusted for the minimumdegree of phase cancellation of the laser output. In an embodiment, acontainer of 400 liters of water was treated with an array of fourlasers.

Each laser had a wavelength of 674 nanometers and a power output in therange of 1.9 to 5.2 milliwatts after passing through the optical devicewhen adjusted for the minimum degree of phase cancellation of the laseroutput. Thus, for this experiment, only water was activated byphotoacoustic resonance (PAR) (to generate activated or lasered water)under the same laser conditions as were used to activate the nutrientformulation or solution.

All four beams were applied to the nutrient solution or water at atrajectory allowing a full traverse of the beam from the surface to thebottom or opposite side of the container or conduit carrying thenutrient solution. In one embodiment, application time of the beam was20 minutes for each system. Thus, there was approximately 96milliwatt-minutes of visible residual beam applied to 400 liters ofnutrient solution to complete the treatment, or about 0.24milliwatt-minutes per liter.

The nutrient formulation, thus activated by photoacoustic resonance(PAR), was then studied for its effects on a cannabis first test groupand compared with a cannabis second test group that was treated withactivated or lasered water and with a cannabis control group that wastreated with unactivated nutrient formula. There were 10 plants in eachof the control group, first test group and second test group. Cannabisplants, in the three groups, were characterized by a growing periodranging from 45 to 60 days (as determined by the rate of growth), aflowering period of 56 to 60 days followed by a drying period of 1 weekin a drying room with circulating air and an additional 2 to 4 weeks inplastic film bags. The first test group was treated with activated orlaser enhanced formula foliar sprayed two times per week at 5 PMthroughout the growing and flowering cycle. An initial application ofthe activated formula was started 7 to 10 days following permanenttransplant. The activated formula was provided in concentrated formwhich was diluted 10 ml to 1 liter of water (ratio of 1 to 100) for thefoliar spray. During the growing phase water used to dilute theactivated formula was in a pH range of 6.8 to 7 while during theflowering phase the pH range of the water was in a range of 5 to 6.

The second test group was treated with activated or lasered water foliarsprayed two times per week at 5 PM throughout the growing and floweringcycle. An initial application of the activated water was started 7 to 10days following permanent transplant. The activated or lasered water wasprovided in 5 gallon containers and applied without dilution.

The control group was treated with unactivated formula foliar sprayedtwo times per week at 5 PM throughout the growing and flowering cycle.An initial application of the unactivated formula was started 7 to 10days following permanent transplant. The unactivated formula wasprovided in concentrated form which was diluted 10 ml to 1 liter ofwater (ratio of 1 to 100) for the foliar spray. During the growing phasewater used to dilute the unactivated formula was in a pH range of 6.8 to7 while during the flowering phase the pH range of the water was in arange of 5 to 6.

The concentrated activated formula, activated water and unactivatedformula were stored at a separation space of at least 33 feet from eachother as well as from conventional fertilizers and/or nutrients used fortreating the three groups. The tracks for the first test, second testand control plants were also isolated from each other by at least 33feet. All three groups were provided with the same growing conditions interms of water, light exposure and conventional fertilizers and/ornutrient schedules.

In one embodiment, 10 flowers from each of the control group, first testgroup and second test group were chosen randomly and analyzed for theircannabinoid concentration. FIG. 7A shows a first table 705 of aplurality of cannabinoids 702 and their respective concentrations inmg/g 706 and percent by mass 707 based on an analysis of the flowerstaken from the control group. FIG. 7B illustrates a second table 710 ofthe plurality of cannabinoids 702 and their respective concentrations inmg/g 712 and percent by mass 714 based on an analysis of the flowerstaken from the second test group (that was treated with activated orlasered water). FIG. 7C illustrated a third table 715 of the pluralityof cannabinoids 702 and their respective concentrations in mg/g 718 andpercent by mass 720 based on an analysis of the flowers taken from thefirst test group (that was treated with activated formula).

Comparing tables 705, 710, 715, in accordance with an aspect, theconcentration of at least the following cannabinoids is modulated:D9-THC increases from 201.71 mg/g (20.17% by mass) in the control groupand 207.80 mg/g (20.78% by mass) in the second test group to 218.35 mg/g(21.83% by mass) in the first test group; and Cannabinol increases from1.37 mg/g (0.14% by mass) in the control group and 1.41 mg/g (0.14% bymass) in the second test group to 2.61 mg/g (0.26% by mass) in the firsttest group. The increase in the concentration of the cannabinoids in thefirst test group, compared to the control and second test group is alsoevident in a corresponding increase in total cannabinoids concentrationfrom 20.9% in the control group and 21.6% in the second test group to22.6% in the first test group.

In other words, the concentration of at least the followingcannabinoids, in the first test group, improves compared to the controlgroup: D9-THC increases by 16.64 mg/g representing an improvement ofabout 8%, and Cannabinol increases by 1.24 mg/g representing animprovement of about 91%. In some embodiments, concentration of at leastthe following cannabinoids, in the first test group, increases by atleast 1% compared to the control group.

FIG. 8A shows a first table 805 and an associated first graph 806 of aplurality of terpenes 802 and their respective concentrations in mg/g808 based on an analysis of the flowers taken from the control group.FIG. 8B shows a second table 815 and an associated second graph 816 ofthe plurality of terpenes 802 and their respective concentrations inmg/g 818 based on an analysis of the flowers taken from the first testgroup.

Comparing tables 805, 815 (and the respectively associated graphs 806,816), in accordance with an aspect, the total concentration 819 of theplurality of terpenes 802 in the first test group is increased comparedto the corresponding total concentration 809 of the plurality ofterpenes 802 in the control group. It should be appreciated thatterpenes are considered to have medicinal or beneficial pharmacologicalcharacteristics without significant harmful side effects and/or reducethe side-effects of other toxic constituents of cannabis. Therefore, anincrease in concentration of the terpenes is desirable.

In some embodiments, concentration of at least the following terpenes ismodulated: alpha-pinene increases from 0.168 mg/g in the control groupto 0.440 mg/g in the first test group representing about 162% increase,myrcene increases from 0.895 mg/g in the control group to 2.906 mg/g inthe first test group representing about 225% increase, beta-pineneincreases from 0.241 mg/g in the control group to 0.650 mg/g in thefirst test group representing about 170% increase, limonene increasesfrom 0.553 mg/g in the control group to 1.926 mg/g in the first testgroup representing about 248% increase, alpha-humulene increases from1.015 mg/g in the control group to 1.332 mg/g in the first test grouprepresenting about 31% increase, linalool increases from 0.212 mg/g inthe control group to 0.455 mg/g in the first test group representingabout 115% increase, terpinolene increases from 0.000 mg/g in thecontrol group to 0.035 mg/g in the first test group, bisabolol increasesfrom 0.077 mg/g in the control group to 0.097 mg/g in the first testgroup representing about 26% increase, caryophyllene increases from2.976 mg/g in the control group to 4.335 mg/g in the first test grouprepresenting about 46% increase.

In some embodiments, concentration of at least the following terpenes,in the first test group, increases by at least 1% compared to thecontrol group: alpha-pinene, myrcene, carene, beta-pinene, limonene,alpha-humulene, linalool, terpinolene, bisabolol, and caryophyllene.

In some embodiments, concentration of at least the following terpenes,in the first test group, is improved compared to the control group:alpha-pinene increases by 0.272 mg/g or at least 1%, myrcene increasesby 2.011 mg/g or at least 1%, beta-pinene increases by 0.409 mg/g or atleast 1%, limonene increases by 1.373 mg/g or at least 1%,alpha-humulene increases by 0.317 mg/g or at least 1%, linaloolincreases by 0.243 mg/g or at least 1%, terpinolene increases by 0.035mg/g or at least 1%, bisabolol increases by 0.02 mg/g or at least 1%,caryophyllene increases by 1.359 mg/g or at least 1%.

In some embodiments, a concentration of total terpenes increases from6.435 mg/g in the control group to 12.206 mg/g in the first test grouprepresenting about 90% increase. In some embodiments, compared to thecontrol group a concentration of total terpenes is increased by at least3 mg/g in the first test group. In some embodiments, compared to thecontrol group a concentration of total terpenes is increased by at least20% in the first test group. In some embodiments, compared to thecontrol group a concentration of total terpenes is increased by 5.771mg/g in the first test group. In some embodiments, compared to thecontrol group a concentration of total terpenes is increased by at least1% in the first test group.

In some embodiments, 10 plants from the control group yielded 9.83pounds (4464 g) of cannabis flower while 10 plants from a second testgroup (laser-activated water) yielded 13.72 pounds (6620 g) of cannabisflower and 10 plants from a first test group (laser-activated nutrientsolution) yielded 14.71 pounds (6680 g) of cannabis flower. In someembodiments, compared to the control group a cannabis flower yield from10 plants is increased by 3.89 pounds, in the second test group,representing an increase of about 40%. In some embodiments, compared tothe control group a cannabis flower yield from 10 plants is increased by4.88 pounds, in the first test group, representing an increase of about50%.In some embodiments, compared to the control group a cannabis floweryield from 10 plants is increased by at least 1% in the first and secondtest groups.

GENERAL OBSERVATIONS

Additional tests across different types of cannabis, including varietiesor strains of cannabis, have shown that in every instance there is asignificant increase in the growth of the plant and the level of yieldand quality of that yield with laser activated, as opposed tonon-activated nutrient formulas.

In accordance with various aspects of the present specification,treatment of cannabis using the activated nutrient solution orformulation (whether laser treated dry fertilizer, wet fertilizer, orjust water) results in:

-   -   Increased yields of cannabis plant (as a whole) in a range of 5%        to 75%, including any increment therein, relative to cannabis        plant treated with the same, but unactivated, liquid nutrient        solution, dry nutrient mix, or water.    -   Enhanced transport of nutrients to the cells of cannabis plant,        in a range of 5% to 400% including any increment therein,        relative to cannabis treated with the same, but unactivated,        liquid nutrient solution, dry nutrient mix, or water.    -   Increased amount of each of the cannabis constituents, listed in        Table 2, in a range of 5% to 75% including any increments        therein, relative to the constituents in cannabis treated with        the same, but unactivated, liquid nutrient solution, dry        nutrient mix, or water.    -   Increased density of cannabis constituents: Cannabinoids,        Flavonoids, Terpenoids, in a range of 5% to 400% including any        increment therein, relative to the constituents in cannabis        treated with the same, but unactivated, liquid nutrient        solution, dry nutrient mix, or water.    -   Increased Brix degree of cannabis plant, in a range of 5% to 75%        including any increment therein, relative to cannabis plant        treated with the same, but unactivated, liquid nutrient        solution, dry nutrient mix, or water.    -   Relative to control cannabis, decreased concentration or        percentages of cannabis constituents having significant harmful        side effects or psychoactive, toxic constituents such as, but        not limited to, the cannabinoids: delta-9-tetrahydrocannabinol        (9-THC) and dela-8-tetrahydrocannabinol (8-THC).    -   Relative to control cannabis, increased concentration or        percentages of cannabis constituents having medicinal or        beneficial pharmacological characteristics without significant        harmful side effects and/or that reduce the side-effects of        other toxic constituents of cannabis. Such beneficial components        comprise, for example, cannabinoids such as cannabigerolic acid,        cannabigerol, cannabichromene, cannabidiolic acid, cannabidiol,        cannabinol, delta-8-tetrahydrocannabinol-11-oic acid. Other        beneficial classes of components include, for example,        nitrogenous compounds, amino acids, proteins, enzymes and        glycoproteins, sugars and related compounds, hydrocarbons,        simple alcohols, simple aldehydes, simple ketones, simple acids,        fatty acids, simple esters and lactones, steroids, terpenoids,        non-cannabinoid phenols, flavonoids, vitamin K, pigments and        elements—each of these classes and constituents thereof have        been described in detail earlier in this specification.

The various embodiments of the present specification have numerousbenefits that include increase in yield per hectare, increase in plantmedicinal value, reduced input costs due to elimination of chemicalfertilizers, improved soil quality and regeneration due to increasednitrogen fixation from the air, reduced requirements for chemicalnitrates by as much as 80%, reduced dependency on, or elimination ofpesticides, enhanced quality, purification of water table by reducingapplied chemicals such as nitrates, greater value per metric ton, andprolonged shelf life. All of the above benefits deliver significantvalue in the chain of cannabis production.

The above examples are merely illustrative of the many applications ofthe system of present invention. Although only a few embodiments of thepresent invention have been described herein, it should be understoodthat the present invention might be embodied in many other specificforms without departing from the spirit or scope of the invention.Therefore, the present examples and embodiments are to be considered asillustrative and not restrictive.

We claim:
 1. A method of growing cannabis comprising: applying anactivated composition to an untreated cannabis crop, wherein saidactivated composition comprises an amount of photoacoustic energydeposited therein in a range of 0.05 to 5 milliwatt-minutes per liter;and wherein, after said application, the treated cannabis crop exhibitsan increased yield in a range of 5% to 50% relative to the untreatedcannabis crop.
 2. The method of claim 1, further comprising: forming anunactivated composition; and applying to said unactivated composition aplurality of ultra-rapid impulses of modulated laser light, saidultra-rapid impulses being defined as impulses with molecular traverserates on the order of 100 nanoseconds to 0.01 femtoseconds.
 3. Themethod of claim 2, wherein said unactivated composition is water.
 4. Themethod of claim 2, wherein said unactivated composition is a drynutrient mix.
 5. The method of claim 2, wherein said unactivatedcomposition is a liquid nutrient solution.
 6. The method of claim 1,wherein said treated cannabis crop exhibits an increase in concentrationof at least one of cannabinoids, nitrogenous compounds, amino acids,proteins, enzymes, glycoproteins, sugars, hydrocarbons, alcohols,aldehydes, ketones, acids, fatty acids, esters, lactones, steroids,terpenoids, non-cannabinoid phenols, flavonoids, vitamins, pigments andelements relative to the untreated cannabis crop.
 7. The method of claim1, wherein said treated cannabis crop has an increased Brix degree in arange of 5% to 75% relative to the untreated cannabis crop.
 8. A methodof growing cannabis comprising: applying an activated composition to anuntreated cannabis crop, wherein said activated composition comprises anamount of photoacoustic energy deposited therein in a range of 0.05 to 5milliwatt-minutes per liter; and wherein, after said application, atleast one of a plurality of cannabinoids constituents of said treatedcannabis crop has an increased amount in a range of greater than 5%relative to the untreated cannabis crop.
 9. The method of claim 8,further comprising: forming an unactivated composition; and applying tosaid unactivated composition a plurality of ultra-rapid impulses ofmodulated laser light, said ultra-rapid impulses being defined asimpulses with molecular traverse rates on the order of 100 nanosecondsto 0.01 femtoseconds.
 10. The method of claim 9, wherein saidunactivated composition is water.
 11. The method of claim 9, whereinsaid unactivated composition is a dry nutrient mix.
 12. The method ofclaim 9, wherein said unactivated composition is a liquid nutrientsolution.
 13. The method of claim 8, wherein said plurality ofcannabinoids constituents comprise at least one of cannabigerolic acid,cannabigerol, cannabichromene, cannabidiolic acid, cannabidiol, andcannabinol.
 14. The method of claim 8, wherein said treated cannabiscrop has an increased Brix degree in a range of greater than 5% relativeto the untreated cannabis crop.
 15. A method of growing cannabiscomprising: applying an activated composition to an untreated cannabiscrop, wherein said activated composition comprises an amount ofphotoacoustic energy deposited therein in a range of 0.05 to 5milliwatt-minutes per liter; and wherein, after said application, atleast one of a plurality of terpene constituents of said treatedcannabis crop is increased by an amount in a range of greater than 5%relative to the untreated cannabis crop.
 16. The method of claim 15,further comprising: forming an unactivated composition; and applying tosaid unactivated composition a plurality of ultra-rapid impulses ofmodulated laser light, said ultra-rapid impulses being defined asimpulses with molecular traverse rates on the order of 100 nanosecondsto 0.01 femtoseconds.
 17. The method of claim 16, wherein saidunactivated composition is water.
 18. The method of claim 16, whereinsaid unactivated composition is a dry nutrient mix.
 19. The method ofclaim 16, wherein said unactivated composition is a liquid nutrientsolution.
 20. The method of claim 15, wherein said plurality of terpeneconstituents comprise at least one of alpha-pinene, myrcene, carene,beta-pinene, limonene, alpha-humulene, linalool, terpinolene, bisabolol,caryophyllene, and humulene.